A Single Patient Compassionate Use of MBM-02 (Tempol) for the Treatment of Prostate Cancer
Condition(s):Prostate CancerLast Updated:May 5, 2021Available
Hide Studies Not Open or Pending
Condition(s):Prostate CancerLast Updated:May 5, 2021Available
Condition(s):Mucositis; Nephrotoxicity; OtotoxicityLast Updated:February 18, 2022Unknown status
Condition(s):Covid19Last Updated:December 6, 2022Terminated
Condition(s):Metastatic CancerLast Updated:September 1, 2022Available
Condition(s):Prostate Cancer Recurrent; Biochemical Recurrent Prostate CancerLast Updated:May 6, 2021Unknown status
Condition(s):Ataxia Telangiectasia Louis-Bar; Ataxia Telangiectasia in Children; Ataxia TelangiectasiaLast Updated:May 17, 2021Unknown status
Condition(s):AlopeciaLast Updated:December 3, 2008Unknown status
Condition(s):Glioblastoma; Glioblastoma MultiformeLast Updated:May 5, 2021Unknown status
Condition(s):Cardiovascular Diseases; Cardiovascular Risk Factor; VasodilationLast Updated:September 21, 2018Completed
Condition(s):Cardiovascular Diseases; Cardiovascular Risk Factor; VasoconstrictionLast Updated:November 5, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.